B
lood pressure (BP) is often elevated in patients with acute ischemic stroke, but value of lowering BP for such patients is controversial, particularly for those receiving intravenous (IV) recombinant tissue plasminogen activator (rt-PA). Several observational studies have identified a linear or U-shaped association between high systolic BP (SBP) on admission or within the first 24 hours with symptomatic intracerebral hemorrhage (sICH), mortality, and poor functional outcomes.
1-3 BP variability is an important trigger of vascular events, 4 and visit-to-visit SBP variability is a powerful predictor of stroke, independently of mean SBP. 5 Similarly, hour-to-hour BP variability during acute stroke also seems to predict stroke outcomes. 6 The present substudy of the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rt-PA Registry investigates associations between early BP variability during this period and outcomes of thrombolysis.
Patients and Methods
The SAMURAI rt-PA registry was created using a multicenter hospital-based retrospective observational design.
7 Six-hundred consecutive patients with acute ischemic stroke who received IV rt-PA (0.6 mg/kg, recommended dosage by the Japanese guidelines) 8 were registered.
Supine BP was measured just before starting IV rt-PA (initial) and at 0, 4, 8, 12, 16, 20 , and 24 hours after completing the administration. Use of antihypertensives, such as IV nicardipine, was permitted if needed according to the guidelines. 8, 9 The maximum (max), minimum (min), and average (mean) of these 8 BP values were calculated. We also calculated the following variability profiles: the difference between max and min (ΔBP), SD ( : Background and Purpose-The present study determines associations between early blood pressure (BP) variability and stroke outcomes after intravenous thrombolysis. Methods-In 527 stroke patients receiving intravenous alteplase (0.6 mg/kg), BP was measured 8 times within the first 25 hours. BP variability was determined as ΔBP (maximum-minimum), standard deviation (SD), coefficient of variation, and successive variation. Results-The systolic BP course was lower among patients with modified Rankin Scale (mRS) 0 to 1 than those without (P<0.001). Most of systolic BP variability profiles were significantly associated with outcomes. Adjusted odds ratios (95% confidence interval) per 10 mm Hg (or 10% for coefficient of variation) on symptomatic intracerebral hemorrhage were as follows: ΔBP, 11 with ≥1-point increase from the baseline National Institutes of Health Stroke Scale score) within the first 36 hours and modified Rankin Scale (mRS) score of 0 to 1 and death at 3 months. Associations between each BP profile and outcomes were determined using binominal logistic regression models adjusted by the known baseline characteristics (see detailed patient information and Statistical Methods in the online-only Data Supplement).
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Results
Among registered patients, 65 with premorbid mRS score 2 to 5, 7 with incomplete BP values, and 1 who died within 24 hours were excluded. Thus, data from 527 patients (182 women, 70.8±11.6 years old; Online Table I shows baseline characteristics) were eligible for analysis. Twenty-three patients (4.4%) had development sICH, 197 (37.4%) had mRS 0 to 1, and 29 (5.5%) died.
The SBP course tended to be higher among patients with sICH than those without (P=0.083), and it was significantly lower among patients with mRS 0 to 1 than those without (P<0.001; Figure) . BP variability profiles were larger in patients receiving antihypertensives just before thrombolysis than the others (online Table II) .
Larger variations in all SBP variability profiles were associated with sICH and death (Table) . Smaller ΔBP was significantly associated with (P=0.043) and smaller successive variation was marginally significantly associated (P=0.081) with mRS 0 to 1. Although larger variations in all diastolic BP variability profiles were associated with sICH and death, no diastolic BP profiles were associated with mRS 0 to 1 (online Figure I and online Table III ).
Discussion
The first major finding of this study was a positive association between all SBP and diastolic BP variability profiles and sICH and death. The second major finding was that SBP levels were lower throughout the first 25 hours after starting rt-PA in patients who had mRS score 0 to 1 than in those who did not. Furthermore, systolic ΔBP was inversely associated with mRS score 0 to 1. Finally, initial BP levels, as well as most of BP values at each time point, did not predict any outcomes.
In a substudy of the Second European-Australasian Acute Stroke Study (ECASS-II), 12 max, mean, and successive variation of 24-hour SBPs predicted hemorrhagic transformation and 3-month outcomes after thrombolysis. In that study, 80% of the patients received thrombolytic therapy within 3 to 6 hours after onset.
11 In our single-center study of IV rt-PA, max, mean, and min of SBPs were inversely associated with 3-month mRS score 0 to 2.
3 A recent single-center study showed that successive variation of SBP higher than the median value is associated with 3-month mRS score 0 to 2, but not with mortality or sICH.
13 Different contributions of BP variability to outcomes among investigations including the present study might be attributable to difference in indicators, measures of variability, or timing of BP measurements.
Contrary to the ECASS-II substudy, 12 initial BP values did not predict any outcomes in the present study. One explanation might be that we documented BP values immediately before starting thrombolysis and, accordingly, some very high BP values would have been modified by antihypertensive drugs. In addition, mental stress, bladder tonus, and other transient stimuli also modulate BP values and, therefore, measuring during the first few hours might not accurately reflect stroke conditions. These findings suggest that BP values determined during the first 24 hours of admission confer an advantage as a predictor of prognosis.
The present study stresses the impact of variability in BP as a predictor of stroke outcomes. These findings indicate that the therapeutic effects of modulating acute BP variability 
Sources of Funding
This study was supported in part by grants-in-aid from the Ministry of Health, Labor, and Welfare of Japan. According to the guidelines, antihypertensive agents were administrated to reduce BP levels to <185/110 mmHg just before rt-PA administration and to maintain the levels at <180/105 mmHg during the first 24 hours thereafter.
Disclosures
Supplemental Methods for Statistical analysis
Data were statistically analyzed using JMP Pro 9.0.2 statistical software (SAS Institute Inc.). The time courses of BP between patients with and without each outcome were compared using a two-way repeated measures analysis of variance. Associations between each BP profile and stroke outcomes were determined using binominal logistic regression models adjusted by the known baseline characteristics. Results were presented as odds ratios (OR: per 10% for CV and per 10 mmHg for others) with 95% confidential intervals (CI) for each BP profile. A probability value < 0.05 was considered significant. Figure S1 .
Supplemental Tables and Figures
Comparisons of time course of DBP according to sICH, mRS value and mortality at three months.
